Komal Gurnani

Principal, pharma launch strategy, at ZS. Since joining ZS in 2011, she has advised many clients on a range of topics including go-to-market strategy and launch differentiation in specialty pharma; commercial organizational design and integrated marketing (commercial, payer and patient); rare disease launch strategy and digitally enabled commercialization; prelaunch strategy and cross-functional unmet needs assessment (commercial, medical and market access); commercial operations optimization and portfolio cost efficiency; execution leadership on large immunology launches; and cross-functional coordination.

A recognized expert and thought leader across marketing advisory, launch planning, portfolio and brand planning, Gurnani regularly publishes on healthcare and pharma industry trends. She has supported 40+ clients across immunology, cardiology, respiratory, diabetes/metabolics, renal-hepatic and oncology.